APPLICATION OF ERIBULIN IN CANCER TREATMENT

摘要

FIELD: medicine.;SUBSTANCE: group of inventions refers to medicine, namely to oncology, and can be used in treating breast cancer. Disclosed methods involve administering an eribulin and a second agent selected from capecitabine, an antimitotic agent, an antitumour agent based on platinum, doxorubicin and Ixabepilone. Erubulin is administered to subject 1, 2, 3, 4, 5 or 6 days or 1–12 weeks before the said second agent. Kit according to the invention contains eribulin and a second agent.;EFFECT: use of inventions enables improving the anticancer effect ensured by the synergetic effect of the combination.;58 cl, 1 tbl, 4 dwg